Alembic Pharma rises after oncology facility completes US FDA audit with 'zero' observations

Alembic Pharmaceuticals added 2.50% to Rs 1277.65 after the company announced the successful completion of the United States Food and Drug Administration (US FDA) inspection for its oncology formulation facility located at Panelav, Gujarat.